Major Bleeding Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy with a Non-vitamin K-Antagonist Oral Anticoagulant, Aspirin, and Clopidogrel

Jul 1, 2017 by in CARDIOLOGY Comments Off on Major Bleeding Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy with a Non-vitamin K-Antagonist Oral Anticoagulant, Aspirin, and Clopidogrel

  Condition Points Total score Stroke risk/year (%) C Congestive heart failure (or left ventricular ejection fraction ≤ 35%) 1 0 0 H Hypertension: blood pressure consistently above 140/90 mmHg…

read more

New-Onset Atrial Fibrillation in a Stable Patient with Remote Percutaneous Coronary Intervention

Jul 1, 2017 by in CARDIOLOGY Comments Off on New-Onset Atrial Fibrillation in a Stable Patient with Remote Percutaneous Coronary Intervention

BMS  (a) Stainless steel (b) Non-stainless steel, cobalt-, or platinum-chrome alloy DES Early generation (a) Durable polymer: sirolimus, paclitaxel eluting  New generation (a) Durable polymer: zotarolimus, everolimus eluting (b) Biodegradable…

read more

Urgent Surgery Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy of Non-vitamin K Antagonist Oral Anticoagulant, Aspirin, and Clopidogrel

Jul 1, 2017 by in CARDIOLOGY Comments Off on Urgent Surgery Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy of Non-vitamin K Antagonist Oral Anticoagulant, Aspirin, and Clopidogrel

CKD stage Description GFR (ml/min per 1.73 m2) 1 Kidney damage with normal or increased GFR ≥90 2 Kidney damage with mild decreased GFR 60–89 3 Moderate decreased GFR 30–59…

read more

Major Bleeding Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy with Vitamin K antagonist, Aspirin, and Clopidogrel

Jul 1, 2017 by in CARDIOLOGY Comments Off on Major Bleeding Early After Percutaneous Coronary Intervention in a Patient with Atrial Fibrillation on Triple Therapy with Vitamin K antagonist, Aspirin, and Clopidogrel

BMS  (a) Stainless steel (b) Non-stainless steel, cobalt- or platinum-chrome alloy DES Early generation (a) Durable polymer: sirolimus- and paclitaxel-eluting  New generation (a) Durable polymer: zotarolimus- and everolimus-eluting (b) Biodegradable…

read more

Atrial Fibrillation on Vitamin K Antagonist Undergoing Elective Percutaneous Coronary Intervention for Stable Effort Angina

Jul 1, 2017 by in CARDIOLOGY Comments Off on Atrial Fibrillation on Vitamin K Antagonist Undergoing Elective Percutaneous Coronary Intervention for Stable Effort Angina

BMS  (a) Stainless steel (b) Non-stainless steel, cobalt- or platinum-chrome alloy DES Early generation (a) Durable polymer: sirolimus, paclitaxel eluting New generation (a) Durable polymer: zotarolimus, everolimus eluting (b) Biodegradable…

read more

Atrial Fibrillation on Vitamin K Antagonist Oral Anticoagulant Undergoing Urgent Percutaneous Coronary Intervention for Non-ST-Elevation Acute Coronary Syndrome

Jul 1, 2017 by in CARDIOLOGY Comments Off on Atrial Fibrillation on Vitamin K Antagonist Oral Anticoagulant Undergoing Urgent Percutaneous Coronary Intervention for Non-ST-Elevation Acute Coronary Syndrome

CKD stage Description GFR (ml/min per 1.73 m2) 1 Kidney damage with normal or increased GFR ≥90 2 Kidney damage with mild decreased GFR 60–89 3 Moderate decreased GFR 30–59…

read more

Atrial Fibrillation on Non-vitamin K Antagonist Oral Anticoagulant Undergoing Elective Percutaneous Coronary Intervention for Stable Effort Angina

Jul 1, 2017 by in CARDIOLOGY Comments Off on Atrial Fibrillation on Non-vitamin K Antagonist Oral Anticoagulant Undergoing Elective Percutaneous Coronary Intervention for Stable Effort Angina

CKD stage Description GFR (ml/min per 1.73 m2) 1 Kidney damage with normal or increased GFR ≥90 2 Kidney damage with mild decreased GFR 60–89 3 Moderate decreased GFR 30–59…

read more

Atrial Fibrillation on Vitamin K Antagonist Undergoing Urgent Percutaneous Coronary Intervention for Non-ST-Elevation Acute Coronary Syndrome

Jul 1, 2017 by in CARDIOLOGY Comments Off on Atrial Fibrillation on Vitamin K Antagonist Undergoing Urgent Percutaneous Coronary Intervention for Non-ST-Elevation Acute Coronary Syndrome

Fig. 3.1 Electrocardiogram (ECG) on admission 3.2 Periprocedural Issues Indication for and timing of CORO/PCI in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) are driven by the risk of adverse…

read more

Atrial Fibrillation on Vitamin K Antagonist Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction

Jul 1, 2017 by in CARDIOLOGY Comments Off on Atrial Fibrillation on Vitamin K Antagonist Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction

Fig. 5.1 Twelve-lead electrocardiogram (ECG) at presentation 5.2 Periprocedural Issues Primary PCI coupled with adjuvant antithrombotic therapy is the current standard of care for patients presenting with STEMI (Fig. 5.2)…

read more
Get Clinical Tree app for offline access